Breaking News

Eikon Therapeutics Expands Operations in New York City

State-of-the-art facility will provide 25,000 square feet of office and lab space for the company’s expanding clinical and research operations.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The biotechnology company Eikon Therapeutics has signed a lease with Alexandria Real Estate Equities, Inc. for its new East Coast base of operations located in the Alexandria Center for Life Science in New York City. The 25,000 square foot mixed-use facility will allow Eikon to establish a clinical development arm, expand upon existing research functions, attract top talent on both U.S. coasts, and explore potential collaborations with entities on the East Coast. Eikon’s chief medical offi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters